Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

78 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Completed

S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia

NCT00492856

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Sutter Cancer Center at Roseville Medical Center Roseville, California, United States
  • Sutter Cancer Center Sacramento, California, United States
  • Stanford Cancer Center Stanford, California, United States
View all 210 locations
View Trial Details
Completed

S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

NCT00551460

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations
  • Sutter Cancer Center at Roseville Medical Center Roseville, California, United States
  • Sutter Cancer Center Sacramento, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut, United States
View all 192 locations
View Trial Details
Completed

Study on Number and Outcome of Pregnancy in Acute Promielocitic Leukaemia (APL) Patients Treated With Chemotherapy

NCT01472107

Conditions
Acute Promyelocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • Azienda Ospedaliera - Nuovo Ospedale "Torrette" Ancona, Italy
  • Unità Operativa Ematologia 1 - Università degli Studi di Bari Bari, Italy
  • Ospedali Riuniti di Bergamo Bergamo, Italy
View all 36 locations
View Trial Details
Completed

Phase III Trial in Acute Promyelocytic Leukemia Patients

NCT00482833

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations
  • Universitätsklinik Innsbruck Hämatologie Onkologie Innsbruck, Austria
  • Krankenhaus der Barmherzigen Schwestern Linz Linz, Austria
  • Universitätsklinik für Innere Medizin III Salzburg Salzburg, Austria
  • Klinikum Bayreuth GmbH Bayreuth, Germany
View all 110 locations
View Trial Details
Completed

Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia

NCT01253070

Conditions
Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11, Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, +12 more
Locations
  • Beebe Medical Center Lewes, Delaware, United States
  • Christiana Care Health System-Christiana Hospital Newark, Delaware, United States
  • AdventHealth Orlando Orlando, Florida, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
View all 43 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes

NCT00369317

Conditions
Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6), +20 more
Locations
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Southern California Permanente Medical Group Downey, California, United States
  • Miller Children's Hospital Long Beach, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 97 locations
View Trial Details
Completed

Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM

NCT04695431

Conditions
Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Hematologic Diseases, +15 more
Locations
  • Standford Cancer Center Palo Alto, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Medizinische Universitat Wien Vienna, Austria
  • Universitatmedizin Mannheim Mannheim, Baden-Wurttemberg, Germany
View Trial Details
Completed

Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy

NCT01404949

Conditions
Acute Promyelocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Northwestern University Evanston, Illinois, United States
  • National Heart, Lung, and Blood Institute (NIH) Bethesda, Maryland, United States
  • Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
View Trial Details

Related conditions